Pages that link to "Item:Q2861803"
From MaRDI portal
The following pages link to A Phase I Bayesian Adaptive Design to Simultaneously Optimize Dose and Schedule Assignments Both Between and Within Patients (Q2861803):
Displaying 5 items.
- Adaptive clinical trial designs for phase I cancer studies (Q2452091) (← links)
- DICE: A Bayesian model for early dose finding in phase I trials with multiple treatment courses (Q6068878) (← links)
- Bayesian dose regimen assessment in early phase oncology incorporating pharmacokinetics and pharmacodynamics (Q6079344) (← links)
- Bayesian modeling of a bivariate toxicity outcome for early phase oncology trials evaluating dose regimens (Q6628011) (← links)
- A Bayesian time-to-event pharmacokinetic model for phase I dose-escalation trials with multiple schedules (Q6629855) (← links)
